COVID-19 Resources

As the COVID-19 pandemic continues to unfold, UVA LVG is committed to helping our UVA faculty, staff, and students innovators, our licensees, and our startup companies navigate the challenges faced during these uncertain times.

We have compiled the following resources to support UVA researchers and entrepreneurs during the COVID-19 pandemic. Sources include the UVA Office of the Vice President for Research, the U.S. Department of Labor, the U.S. Small Business AdministrationThe City of Charlottesville Office of Economic DevelopmentCvilleBioHubVirginia.GovVirginia SBDC, and many others. Thank you for making this information available.

In accordance with UVA's operations policy, our team is working remotely and available to assist via phone, email and zoom. We will continue to update this list, and welcome feedback and additional resources. Please email us at

Last updated: Thursday, July 30, 2020 

COVID-19 Tech Licensing Guidelines

The UVA Licensing & Ventures Group had adopted the following COVID-19 Licensing Guidelines put forth by leading technology transfer industry organization, AUTM.

The guidelines are as follows:

  1. Technology transfer accelerates innovations that impact society and promotes the broad distribution of public health solutions. We encourage intellectual property (IP) owners to adopt a COVID-19 licensing strategy that facilitates rapid pandemic response by licensees and to make the execution of associated transactions a top priority.
  2. For most technologies, where legally possible, this strategy is best accomplished by adopting time-limited, non-exclusive royalty-free licenses, in exchange for the licensees’ commitment to rapidly make and broadly distribute products and services to prevent, diagnose, treat and contain COVID-19 and protect healthcare workers during the pandemic (as defined by the World Health Organization).
  3. Licenses may subsequently convert to a more typical commercial license as appropriate. Licenses must also preserve the licensor’s freedom to publish and use the intellectual property for teaching and research.

To see the full list of university signatories, visit the AUTM website.

University of Virginia

UVA Research Guidelines for Gradual Reopening

(Updated on May 28, 2020)

On May 21, the Office of the Vice President for Research, the Office of the Executive Vice President and Provost released guidelines for a gradual reopening of research activity on Grounds. In order to ensure safety and sustainability, the plan will roll out in phases and will be supplemented by additional guidelines per each school and department. 

Read the full announcement here

Read the full research ramp-up guidance here

COVID-19 Translational Research Funds

The Ivy Foundation COVID-19 Translational Research Fund

The Charlottesville-based Ivy Foundation has committed $2 million to accelerate biomedical research focused on COVID-19 at the University of Virginia. The Ivy Foundation COVID-19 Translational Research Fund will support critical research that addresses COVID-19 diagnosis, treatment options, vaccine development and healthcare worker protection needs.

This new expendable fund will be administered through the Office of the Vice President for Research. It will be used to award grants under a framework similar to that of the foundation’s Ivy Biomedical Innovation Fund, which was created in 2008 to support biomedical innovation and translational research projects at UVA that address unmet clinical needs and have a realistic path to delivering improvements in health care.

Application Deadline (passed): June 22, 2020 5:00 P.M.

Awards Announced: July 22, 2020

Award Funding Starts: August 1, 2020

Manning Fund for COVID-19 Research

The Manning Fund for COVID-19 Research is a newly established innovation fund co-managed by the Provost and the VPR offices for supporting research focused on testing, therapies, vaccines, and ways to reopen society. The intent of this fund is to support practically oriented research on COVID-19 related topics that can be acted upon and/or preferably has a commercialization potential. 

Examples of desirable outcomes include improved diagnosis and treatment of disease through new medical devices, biomarkers for diagnostics, therapeutic targets and agents, new clinical adoption of existing tools, and innovative tools for the reopening of society.

Although not required, it is anticipated that most projects will result in new intellectual property, commercial partnerships, or lead to start-ups.

Target size of grant: up to $100k per project. Strong budget justification is required.

Duration: One year maximum from start to submission of the final report. Reallocation of unspent funds are not allowed.

Proposals will be evaluated based on its intellectual merit, practicality/viability, societal impact, commercialization potential, and qualifications of the researcher/team.

Application Deadline (passed): Friday, May 15, 2020

Awards Announced: Friday, May 29, 2020 - List of recipients

Award Funding Starts: Monday, June 1, 2020

Funding for Research Related to COVID19

National Research Funding

The National Institutes of Health 

NIH mobilizes national innovation initiative for COVID-19 diagnostics (April 29, 2020) 

National Science Foundation (NSF) Opportunities:

On-going; Non-medical, non-clinical-care research on modeling and understanding the spread of COVID-19, inform/educate on science of virus transmission and prevention

Biotechnology Innovation Organization (BIO)

BIO Coronavirus Hub

The BIO Coronavirus Hub is the primary life science-focused resource to connect companies that have relevant supplies, capacities, and resources to share, with those companies, researchers, or healthcare providers that need them.

Virginia Resources & Funding

Virginia Research & Startup Funding 

Virginia Catalyst looks to fund innovative projects working on solutions for #COVID19 as they announce grant funding opportunities ranging from $200-800K. LOIs due June 30, 2020. 

Past Opportunities

Southeast Life Sciences is hosting a virtual PitchRounds competition for early-stage southeastern companies working on Covid-19 products. They are accepting applications until May 22 through the F6S application. They encourage southeast-based early stage medtech and life science companies in any aspect of healthcare - diagnostics, treatments, vaccines, telehealth technologies, devices and even hygienics and PPE to apply. More information.

Virginia Funding & Resources for Small Businesses 

SBDC COVID-19 Resources for Small Businesses

SBA Coronavirus Pandemic Disaster Loan Details

Small Business Administration (SBA) Economic Injury Disaster Loans

Virginia has officially received an Economic Injury Disaster Loan declaration from the U.S. Small Business Administration (SBA). 

Small businesses and non-profits located throughout the state can now apply for a loan of up to $2 million from the SBA to pay fixed debts, payroll, accounts payable, and other expenses. 

To submit a loan application for the SBA Economic Injury Disaster Loan program, please visit:

Payment Extension and Waiver of Late Payment Penalties

Businesses impacted by coronavirus can request an extension of the due date for filing and payment of their February 2020 sales tax return due March 20, 2020, for 30 days. When granted, businesses will be able to file and pay no later than April 20, 2020 with a waiver of any penalties.

The Virginia Department of Taxation is extending the due date of payment of Virginia individuals and corporate income taxes. While filing deadlines remain the same, the due date for individual and corporate income tax will now be June 1, 2020.

Please note that interest will still accrue, so taxpayers who are able to pay by the original deadlines should do so.

More information: Virginia Tax Online Services for Businesses

The Virginia Employment Commission no longer requires the one-week waiting period so workers are able to receive benefits right away. For more information visit HERE.

Virginia 30 Day Fund Forgivable loans for Virginia small businesses 

Charlottesville Resources & Funding

The City of Charlottesville Office of Economic Development (OED) and the Charlottesville Economic Development Authority (CEDA) are offering new funding programs for City businesses. Current opportunities include:

  • Business Equity Fund (BEF) Resiliency Loan for socially disadvantaged City businesses. Pre-screen application now available HERE.
  • Growing Opportunities (GO) Hire Grant for wage subsidies and training. Applications open April 13. Contact for more information
  • Building Resilience Among Charlottesville Entrepreneurs (BRACE) Grant – Application period now closed.

SupportCville is a grassroots community resource where locals can ask for and provide help to neighbors and organizations in need. Our healthcare community is urgently seeking supplies including face masks, gloves, household cleaners, and more. If you have supplies to donate click here: Equip Cville.

Webinars & Virtual Events


UVA Lifetime Learning | Engaging the Mind | UVA Research Discovery: Advancing Ideas that Enrich and Improve Lives

As the University of Virginia navigates the uncertainty of the COVID-19 pandemic alongside the City of Charlottesville, the Commonwealth, and the world, its vibrant research community of innovative thinkers continues to make bold discoveries every day. A disruption this significant also catapults resourcefulness–from the rapid production of a COVID-19 test to the personal protective equipment created in 3D printing labs across Grounds. Michael Straightiff, executive director of the UVA Licensing & Ventures Group, will discuss how research commercialization creates opportunities for students, faculty, and alumni and advances ideas that enrich and improve lives, even during tumultuous times.

Watch here: 

Virginia BIO + VA Catalyst | How to Score High and Get Funding

Virginia Catalyst and Virginia Bio co-hosted a special webinar that featured a panel of experts sharing what it takes to score highly and get funding.
Panel members:

  • Mike Grisham, President and CEO, Virginia Catalyst, Founder and CEO, GPB Scientific, Inc.
  • Mickey Kim, former Senior Vice President, Research and Commercialization, Inova Translational Medicine Institute
  • James Powers, Chairman and CEO, HemoShear Theapeutics, LLC
  • Thomas D. Roberts III, General Partner, Harbert Growth Partners, Harbert Management Corporation

Watch here:

UVA Research Town Hall 

Liz Magill and Melur (Ram) Ramasubramanian hosted a Research Town Hall to address future plans and timelines for a phased approach to ramp research back up. They spoke on Wednesday, May 13th about developing policies and procedures for resuming research capacity.

Watch here: 

UVA Research: Tackling the COVID-19 Crisis 

COVID-19 pandemic has upended life as we know it around the globe. UVA researchers are meeting the challenges of the virus through their expertise in detection, testing, treatment, and prevention. Melur “Ram” Ramasubramanian, the Vice President for Research at UVA, will moderate a discussion with Madhav Marathe, Engineering/Biocomplexity; Amy Mathers, Patrick E. H. Jackson and Steven Zeichner, School of Medicine.

Watch here:

T3PO Webinar Tech Transfer + Telecommuting: Productivity and Operations

UCLA Technology Development Group hosted a webinar with industry veterans and current tech transfer leaders to discuss how offices are coping with the COVID-19 crisis, what lessons can be learned from past crises and how to begin planning for recovery. LVG Executive Director Michael Straightiff joined the conversation. 

Watch the recorded webinar here: 

City of Charlottesville Office of Economic Development and Albemarle County Economic Development: COVID-19 Business Resiliency & Recovery Webinar Series

Due to the impact that COVID-19 is having on local businesses, the City of Charlottesville Office of Economic Development and Albemarle County Economic Development are offering a three-part webinar series for area businesses on resiliency and recovery. Webinars will be facilitated by David Deaton of Deaton Group, which helps businesses overcome their toughest obstacles and reach new levels of success through planning and sound strategy. There will be opportunities for webinar attendees to engage with the speaker and other businesses in attendance to allow for topic discussion and idea sharing.

Watch recorded webinars here:

UVA CLUBS: On Air with Dr. Bill Petri 

The UVA Clubs program and UVA's School of Medicine invite you to join infectious disease expert Dr. Bill Petri (GSAS '80, MED '82, '88) for a private conference call to discuss UVA Health’s role in combating COVID-19. Dr. Petri—vice chair for research in the Department of Medicine, Wade Hampton Frost Professor of Medicine, and Professor of Medicine, Microbiology, Immunology and Cancer Biology, and Pathology—is part of a team at the University working to create a vaccine for a potential second generation of the coronavirus. He will share his thoughts about the pandemic and answer live questions from the audience.

Watch the recorded conversation here:

UVA Batten School Expert Chat Series

Two UVA professors developed an innovative new air-filtration venture. Then the pandemic hit. Hear from two UVA professors -- Batten professor Bala Mulloth and chemical engineering professor Gaurav Giri, co-founders of Hava, Inc., about how they are developing a product uniquely positioned to address PPE needs arising from the COVID-19 pandemic. 

Watch the recorded webinar here: